SC Filed 2024-05-30 Event — SEC 0001193805-24-000728 →

Flynn James E → BiomX Inc. PHGE

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 7/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: -8.8%

Filer track record (5 filings): 0% 90d win rate, +0.0% 90d edge
Short interest building (+83.3% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

40 filings by this filer

39 other filings in the data moat

Short Interest · settle 2026-08-31

DTC 1.00

623,734 shares short · +83.3% vs prior

Other 13D/G Filings on BiomX Inc.

Filed	Form	Filer	Stake	Shares
2026-10-06	SCHEDULE 13D/A	Mayers Ventures LLC	—	195,000	view →
2026-09-17	SCHEDULE 13D	Mayers Ventures LLC	4.86%	130,000	view →
2026-09-15	SCHEDULE 13D/A	T3 Defense Inc.	—	156,796	view →
2026-06-16	SCHEDULE 13D/A	Flynn James E	4.70%	266,424	view →
2026-05-28	SCHEDULE 13D/A	Flynn James E	8.09%	444,703	view →
2026-04-10	SCHEDULE 13D	T3 Defense Inc.	19.87%	1,300,000	view →
2025-03-03	SCHEDULE	Flynn James E	9.99%	15,558,445	view →
2024-07-11	SC	Flynn James E	—	—	view →
2023-03-17	SC	OrbiMed Israel BioFund GP Limited Partnership	—	—	view →

Other Filings by Flynn James E

Filed	Form	Issuer	Stake	Shares
2026-06-16	SCHEDULE 13D/A	BiomX Inc. PHGE	4.70%	266,424	view →
2026-05-28	SCHEDULE 13D/A	BiomX Inc. PHGE	8.09%	444,703	view →
2025-07-31	SCHEDULE	Larimar Therapeutics, Inc. LRMR	35.81%	30,667,474	view →
2025-03-24	SCHEDULE	ARS Pharmaceuticals, Inc. SPRY	10.72%	10,514,657	view →
2025-03-03	SCHEDULE	BiomX Inc. PHGE	9.99%	15,558,445	view →
2025-02-25	SCHEDULE	Singular Genomics Systems, Inc.	100.00%	1,000	view →
2025-01-28	SCHEDULE	Acutus Medical, Inc.	9.10%	5,492,725	view →
2025-01-23	SCHEDULE	Acutus Medical, Inc.	9.10%	9,705,857	view →
2024-07-11	SC	BiomX Inc. PHGE	—	—	view →
2023-05-23	SC	CalciMedica, Inc. CALC	—	—	view →
2023-03-17	SC	Larimar Therapeutics, Inc. LRMR	—	—	view →
2023-01-17	SC	Oncorus, Inc.	—	—	view →
2022-09-16	SC	Larimar Therapeutics, Inc. LRMR	—	—	view →
2022-07-05	SC	Acutus Medical, Inc.	—	—	view →
2022-04-27	SC	Acutus Medical, Inc.	—	—	view →
2021-11-19	SC	Oncology Institute, Inc. TOIIW	—	—	view →
2021-08-26	SC	Acutus Medical, Inc.	—	—	view →
2021-07-21	SC	Acutus Medical, Inc.	—	—	view →
2021-07-13	SC	Acutus Medical, Inc.	—	—	view →
2021-07-02	SC	Larimar Therapeutics, Inc. LRMR	—	—	view →

Showing 20 of 39

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →